Klarman Family Foundation Grants Program in Eating Disorders Research 2012 Award Recipients
|
|
- Richard Norris
- 5 years ago
- Views:
Transcription
1 Klarman Family Foundation Grants Program in Eating Disorders Research 2012 Award Recipients Two-Year Awards Cynthia Bulik, Ph.D. Director, UNC Eating Disorders Program University of North Carolina at Chapel Hill Determining the Role of Uncommon Exon Variation in Anorexia Nervosa Key Words: Anorexia Nervosa, Genetic, Exon Variation As part of the Genetic Consortium for Anorexia Nervosa (GCAN) and Wellcome Trust Case Control Consortium 3 (WTCCC3), we have amassed the largest anorexia nervosa (AN) sample in the world. We propose a well-powered evaluation of the hypothesis that uncommon coding variation plays a role in AN. We propose to evaluate the role of uncommon exon variation in AN in 3,000 female cases and 3,000 archived matched controls in a cost-effective manner by using the Illumina HumanExome chip, which captures missense and nonsense coding variation with MAF =0.005, and a substantial fraction with MAF This chip contains ~230K missense and nonsense coding variants identified via exome sequencing of 12,028 European individuals. The chip contains SNPs from the Psychiatric GWAS Consortium mega-analyses for autism, major depression, schizophrenia, bipolar disorder, and attention deficit hyperactivity disorder. We will genotype AN cases and controls using the Illumina HumanExome chip and conduct rigorous QC. We will evaluate the role of uncommon coding variants in AN conducting single SNP tests along with tests that aggregate variation within exons and genes, and will incorporate appropriately selected covariates and control for potential biases (e.g., population stratification). We will aim to identify biological pathways for AN with high confidence by rigorous assessment of the extent to which genomic results are enriched for smaller p-values in genes from both classical and novel empirical pathways. Finally, we will compare our results with exome chip genotyping conducted for other psychiatric disorders (autism spectrum disorders, bipolar disorder, schizophrenia, and attention deficit hyperactivity disorder) in order to look for shared genetic risk factors. The proposed study will provide a rigorous and well-powered evaluation of the role of uncommon exon variation in AN. If variants are identified, these discoveries could provide rapid and actionable insights into the genetic causes of AN.
2 Kathryn Cunningham, Ph.D. Chauncey Leake Distinguished Professor of Pharmacology University of Texas Medical Branch Fine-Tuning the 5-HT2AR:5-HT2CR Rheostat for Therapeutics in Binge Eating Disorder Key Words: Binge Eating Disorder, Serotonin, 5-HT2AR, 5-HT2CR, Heterodimer, Drug Discovery Binge eating disorder (BED) is the most prevalent eating disorder in the U.S., and is linked to severe obesity and psychological and medical morbidity. Impulsivity and behavioral disinhibition factor into the multifaceted determinants that underlie the etiology of BED and its evolving pathogenesis. Our central hypothesis is that impulsive action and binge eating are mechanistically-linked to disrupted serotonin (5-HT) signaling through the 5-HT2A receptor (5-HT2AR) and 5-HT2CR in brain circuits that drive the incentive-motivational salience of food and cues that predict food. We postulate that 5-HT2AR:5-HT2CR homeostasis in the corticostriatal circuit sustains behavioral inhibition. Our discovery that 5-HT2AR:5-HT2CR heteromeric complexes exist in the brain, and that HI rats exhibit a deficit in heteromer expression relative to LI rats, supports the innovative concept that 5-HT2AR:5-HT2CR heteromeric signaling in single neurons may subserve the role of "rheostat" to fine tune neuronal function and behavioral control. Furthermore, we propose the provocative, high risk idea that a bivalent 5-HT2AR antagonist:5-ht2cr agonist may most effectively suppress both impulsivity and binge eating through promotion or stabilization of heteromeric formation. To this end, we will 1) establish the reciprocal association between impulsivity and binge eating, 2) demonstrate that impulsivity and binge eating impact the reinforcing efficacy of sweet-fat food and associated cues, and 3) explore the 5- HT2AR:5-HT2CR heterodimer as a neuronal rheostat to control impulsivity and binge eating. This innovative project addresses a fundamental gap in our knowledge of how the neural and behavioral aspects of impulsivity are related to binge eating and represents the first step in a continuum of research that may lead to the targeted development of pharmacological strategies to restore 5-HT2AR:5-HT2CR homeostasis and minimize deleterious behaviors that promote aggregate impulsivity/bed.
3 Bingshan Li, Ph.D. Assistant Professor of Human Genetics Vanderbilt University Medical Center Mapping and Functional Characterization of Genetic Variants Associated with Anorexia Nervosa Key Words: Anorexia, Gene Mapping, Complex Diseases, Rare Variants, Linkage and Association Analysis, Genome Wide Association Studies, Whole Exome Sequencing, Transgenic Mouse Anorexia Nervosa (AN) is a serious psychiatric disease characterized by inability to maintain a minimal normal weight, persistent fear of gaining weight and preoccupation about body shape. It affects 0.5-1% of the population and females are 10 times more than males to be affected. AN has the highest mortality rate among all psychiatric disorders with an estimated standard mortality rate over 10. Traditionally AN has been viewed as a disease influenced by sociocultural and environmental factors. However this view was recently challenged and family and twin studies showed a great genetic basis of AN. It is estimated that the heritability of AN is 56-75% from different studies and share environments account for negligible relative resemblance. All these lines of evidence suggest a strong genetic component of AN. However little is known about the biological mechanisms of AN and previous studies are often inconsistent due to the lack of understanding of the genetic basis of AN. Therefore it is crucial to identify genetic factors and to investigate their pathophysiological mechanisms for AN to have effective prevention, diagnosis and treatment in the long run. In the current AN GWAS we are involved we have successfully identified a single nucleotide polymorphism with unequivocal genome wide significance, providing a strong candidate gene for elucidating the genetic etiology of AN. To fine map the variants responsible for this GWAS signal and to identify additional genes associated with AN, in this study we aim to have a comprehensive and unbiased survey of the entire coding regions to identify genetic variants associated with AN via whole exome sequencing of our complex pedigrees, to replicate our initial findings in additional samples and to investigate the functional roles of these genetic variants in model organisms.
4 Marina Picciotto, Ph.D. Professor of Psychiatry Yale University Acetylcholine: A Novel Regulator of Circuits Involved in Food Intake and Eating Disorders Key Words: Food Intake, Nicotinic Acetylcholine Receptors, Nicotine, Hypothalamus, Arcuate Nucleus The propensity for development of eating disorders is complex and likely involves many brain systems, in addition to environmental factors such as stress. We hypothesize that abnormalities in acetylcholine signaling in the brain could increase susceptibility to eating disorders. It is known that smokers are leaner than nonsmokers and use cigarettes to control appetite. We have found that nicotine, the primary psychoactive component in tobacco, highjacks nicotinic acetylcholine receptors (nachrs) in the arcuate nucleus of the hypothalamus (ARC) to decrease food intake. The endogenous neurotransmitter that excites nachrs is acetylcholine; thus, release of acetylcholine in ARC is likely to be important in matching nutrient need to food intake. Acetylcholine is released in several brain areas in response to stress, but the source of acetylcholine input to the ARC is not known. Anatomical studies in Aim 1 will therefore identify cholinergic inputs to ARC. In addition, nachr subtypes in the ARC have not been fully identified and molecular studies in Aim 2 will identify the subunits expressed in POMC and NPY neurons. The effect of cholinergic input to the ARC on food intake has not been studied and optogenetic studies in Aim 3 will provide mechanistic data on the effects of acetylcholine release on food intake. We propose that stress-induced acetylcholine release in the ARC induces satiety even when calorie needs are high. In the behavioral studies in Aim 4 we will determine whether stressinduced anorexia can be blocked by genetic knockdown of specific nachrs in ARC. Future studies can investigate the hypothesis that nachr occupancy is altered in individuals with eating disorders, addressing the hypothesis that acetylcholine contributes to their etiology. Targeting the acetylcholine system may therefore be a novel strategy for therapeutic development to treat those suffering from eating disorders.
5 Leslie B. Vosshall, Ph.D. Professor The Rockefeller University G Protein-Coupled Receptors Regulating the Sensation of Hunger and Satiety Key Words: Drosophila melanogaster, G Protein-Coupled Receptors, TALENs, Post- Fasting Feeding Response, EXPRESSO Automated Feeding Assay The perception of hunger is a central control mechanism that allows humans and other animals to regulate food intake. An integrated system of external sensory input works together with peripheral body organs and the central nervous system to produce the sensations of hunger or satiety. The mechanisms that regulate the perception of hunger and satiety are poorly understood in any animal. A number of peptide hormones that suppress or enhance feeding behavior in animals have been identified. These activate receptors that are members of the G proteincoupled receptor (GPCR) superfamily. The goal of this project is to perform a comprehensive analysis of GPCRs in the genome of the fly, Drosophila melanogaster, and identify and characterize those that regulate feeding behavior. In preliminary studies, we identified mutations in 5 fly GPCRs that disrupt the sensation of hunger and developed an automated instrument called EXPRESSO that measures real-time food consumption, which will greatly accelerate the pace of this project. Two specific aims are proposed: Specific Aim 1: Identification of GPCRs regulating feeding behavior The EXPRESSO instrument will be used to perform a high-throughput screen of GPCRs and neuropeptides to identify those with a role in fly feeding behavior. The goal is to identify novel pathways regulating feeding behavior, which may be applicable to understanding eating behavior and its disorders in humans. Specific Aim 2: Mechanistic analysis of GPCRs regulating feeding behavior We will analyze the gene expression and visualize the neural circuits that express candidate feeding-related GPCRs and neuropeptides. Transgenic reagents will allow us to manipulate the function of neurons expressing these GPCRs as well as permitting in vivo calcium imaging of the circuit in different feeding states. The goal is to understand how these GPCRs participate in the sensation of hunger or satiety and the promotion or suppression of feeding.
6 Yong Xu, M.D., Ph.D. Assistant Professor Baylor College of Medicine A Central Estrogen-5-HT Circuit Regulates Binge Eating Key Words: Estrogens, 5-HT, Brain, Receptor, Binge Eating Binge eating, defined as the ingestion of a large amount of food in a brief period of time, afflicts approximately 5% of US adults and constitutes a significant public health concern. The pathophysiology of binge eating is poorly understood. Impaired central 5-hydroxytryptamine (5-HT) signals are associated with binge behavior and increased brain 5-HT content can inhibit binge eating in patients or animals. Interestingly, estrogens, which can act on central 5-HT neurons, also exhibit anti-binge properties. These findings led to a general hypothesis that the brain estrogen-5-ht circuit plays a physiologically relevant role in binge behavior. We will test this hypothesis with the following two Aims: Aim 1: To determine whether activation/inhibition of brain 5-HT neurons inhibits/potentiates binge eating. We will use newly developed DREADD viruses which allow activation or inhibition of selective subsets of neurons that express Cre-recombinase. The viruses will be stereotaxically delivered into the dorsal raphe nucleus (where brain 5-HT neurons are located) of SERT-Cre mice. This will selectively activate or inhibit 5-HT neurons. We will test if changes in 5-HT neural activities regulate binge eating. Aim 2: To determine whether estrogen receptor-alpha (ERalpha) expressed by brain 5- HT neurons is required to mediate anti-binge effects of estrogens. We will use the Cre-loxP strategy to generate mice lacking ERalpha only in 5-HT neurons. We will use these mice to determine if loss of ERalpha in 5-HT neurons attenuates anti-binge effects of estrogens. The proposed experiments will use the powerful genetic mouse models to delineate the complex brain circuits in the context of binge behavior. Results from these studies may not only reveal the fundamental mechanisms underlying the development of binge behavior, but also we may provide rational targets for the development of novel drugs that can treat binge eating and other related eating disorders.
7 One-Year Awards Kenneth Carr, Ph.D. Associate Professor NYU Medical Center / NYU School of Medicine Effects of Food Restriction on Sucrose-Induced AMPA Receptor Trafficking and Behavior Key Words: Food Restriction, Nucleus Accumbens, AMPA Receptors, Synaptic Plasticity, Binge Eating Food restriction is a risk factor for the development of binge pathology. In the laboratory, food restriction induces neuroadaptations in brain reward circuitry that are likely to be among those that facilitate survival during periods of food scarcity in the wild. However, upregulation of mechanisms that promote foraging, reward-related learning and ingestive behavior may pose a hazard when food restriction is selfimposed in an ecology of abundant, palatable, energy-dense food. Past research of our laboratory indicates that food restriction upregulates D-1 dopamine receptor signaling in nucleus accumbens (NAc). Downstream consequences include increased phosphorylation of the AMPA receptor GluA1 subunit on Ser845, which enhances AMPA currents and facilitates trafficking to the postsynapse. Both cocaine and consumption of 10% sucrose increased GluA1 phosphorylation in food-restricted but not ad libitum fed rats. Further, episodic intake of 10% sucrose increased synaptic delivery of AMPA receptors, with marked increases in GluA1 and GluA2 in NAc postsynaptic density (PSD). In behavioral studies, NAc microinjection of an antagonist of GluA2-lacking AMPA receptors decreased the rewarding effect of D-1 receptor stimulation in food-restricted but not ad libitum fed rats, and slowed consumption of a small high sucrose meal. Microinjection of a nonspecific AMPA receptor antagonist blocked the conditioned hyperactivity of food-restricted rats expecting the meal. Given that AMPA receptor trafficking mediates experience-dependent behavioral plasticity, and food restriction is an important factor clinically as well as in animal models of binge eating, these findings suggest that AMPA receptor trafficking could play a role in the genesis of binge pathology. This pilot project will (i) evaluate the subunit composition of AMPA receptors in the NAc PSD following sucrose intake and (ii) determine whether a history of sucrose intake during food restriction alters AMPA receptor trafficking and sucrose-directed behavior in rats that have returned to ad libitum feeding.
8 Andres Lozano, M.D., Ph.D. Professor of Surgery University Health Network Deep Brain Stimulation for the Treatment of Refractory Anorexia Nervosa: Pilot Trial Key Words: Deep Brain Stimulation, Neurocircuitry, Anxiety, Neuroanatomy, Clinical Trial, Anterior cingulate Although advances in understanding Anorexia Nervosa (AN) from neuroscientific and genetic perspectives have been made, these have thus far not translated into durable and effective treatments. Deep Brain Stimulation (DBS) is a non-lesional, reversible and targeted surgical therapy, that has been used for over 25 years in the management of movement disorders, such as Parkinson's Disease. Given overlapping neural circuits and co-morbidity between the neurologic and psychiatric disorders, DBS has begun to be explored in refractory psychiatric disease, with promising results in Major Depression. Several of the cardinal symptoms of AN, including depressed mood, anxiety, and preoccupation with body-image, can be mapped to distinct emotion- and actionregulating cortical-subcortical circuits comprised of key structural nodes. We propose a pilot trial of DBS in refractory AN, that targets two such structures, the subgenual cingulate gyrus (SCG), and nucleus accumbens (NAcc). Broadly, this study aims to establish the short and long-term safety of DBS in patients with treatment resistant AN and obtain evidence of initial efficacy. Specifically, we will use psychometric measures of AN severity, depression, anxiety, reward and quality-of-life, as well as neuroimaging with positron emission tomography (PET) and Magnetic Resonance Imaging (MRI) to track the short- and long-term influence of DBS on clinical and imaging (structural and functional) outcomes. Twelve patients will be enrolled in this single-arm, non-blinded study, with 6 receiving SCG and 6 NAcc DBS. Device activation will take place at 1-2 weeks post-surgery, and patients will be closely followed for the duration of the oneyear study. We hypothesize that DBS is a safe and effective procedure in patients with refractory AN, as evidenced by minimal adverse events and improvements in baseline clinical and imaging measures at 6 months and 1 year. This would represent a significant step forward in the care of the most severely afflicted anorexic patients.
9 Jacqueline McGinty, Ph.D. Professor of Neurosciences Medical University of South Carolina Prefrontal Cortical BDNF and High Fat Food Seeking Key Words: BDNF, Prefrontal Cortex, Epigenetics, Obesity, High Fat Food Seeking, Self- Administration Repeated bouts of excessive food consumption in the absence of energy deprivation are characteristic of binge eating that is associated with dysregulated energy balance and eating disorders, such as bullemia and obesity. To control overconsumption of palatable sugary or high fat foods (HFF), individuals attempt to restrict their access to energy dense foods by dieting but relapse to palatable food-seeking and binge eating commonly overcome self-control. In contrast to the considerable attention paid to the relationship between homeostatic regulation of energy balance and food intake, the neurobiological mechanisms that contribute to seeking and overeating palatable foods ("hedonic" eating) are not well understood. In a manner that may be similar to addictive drug-seeking, dopamine and glutamate in the prefrontal cortex (PFC) and nucleus accumbens (NAc) are implicated in stress and cue-induced food-seeking. Intriguingly, brain-derived neurotrophic factor (BDNF), a critical mediator of food intake and energy balance, is not only expressed in the hypothalamus but in two critical reward-related pathways, PFC-NAc neurons, where it is a key regulator of glutamate transmission, and ventral tegmental area (VTA)-NAc neurons, where it is a key regulator of dopamine transmission. Although Bdnf knockdown in the ventromedial hypothalamus augments HFF and standard chow consumption and Bdnf knockdown in the VTA augments only HFF consumption, the role of corticolimbic BDNF in hedonic food-seeking is completely unknown. In contrast, BDNF has emerged as a key regulator of addictive drug-seeking. For example, BDNF infusion into the dorsomedial PFC at the end of restricted access cocaine self-administration suppresses subsequent cocaine-seeking in a phospho-erkdependent manner. Thus, in this pilot study, we propose to investigate (1) the effects of HFF self-administration and HFF-seeking on BDNF-related chromatin remodeling, and gene and protein expression in the PFC and NAc and (2) whether intra-pfc BDNF infusion decreases HFF-seeking in rats with a HFF self-administration history.
Internal Regulation II Energy
Internal Regulation II Energy Reading: BCP Chapter 16 lookfordiagnosis.com Homeostasis Biologically, what is necessary for life is a coordinated set of chemical reactions. These reactions take place in
More informationGhrelin mediates stressinduced. behavior in mice. Chuang et al 2011 L3: Love, Lust, Labor
Ghrelin mediates stressinduced food-reward behavior in mice Chuang et al 2011 L3: Love, Lust, Labor Agenda Introduction What is Ghrelin? Previous Models New model Methods Results Discussion Conclusion
More informationKlarman Family Foundation Grants Program in Eating Disorders Research 2010 Award Recipients
Klarman Family Foundation Grants Program in Eating Disorders Research 2010 Award Recipients Two-Year Awards Chiye Aoki, Ph.D. Professor of Neural Science and Biology New York University The Role of GABA
More information590,000 deaths can be attributed to an addictive substance in some way
Mortality and morbidity attributable to use of addictive substances in the United States. The Association of American Physicians from 1999 60 million tobacco smokers in the U.S. 14 million dependent on
More informationThe possibility of deep brain stimulation to treat eating disorders.
The possibility of deep brain stimulation to treat eating disorders. Andres M Lozano MD PhD Professor and Dan Family Chair of Neurosurgery Canada Research Chair in Neuroscience Toronto Western Hospital
More informationMOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre
1 MOLECULAR BIOLOGY OF DRUG ADDICTION Sylvane Desrivières, SGDP Centre Reward 2 Humans, as well as other organisms engage in behaviours that are rewarding The pleasurable feelings provide positive reinforcement
More informationNeurobiology of Addiction
Neurobiology of Addiction Domenic A. Ciraulo, MD Director of Alcohol Pharmacotherapy Research Center for Addiction Medicine Department of Psychiatry Massachusetts General Hospital Disclosure Neither I
More informationNeurobiology of Addiction
Neurobiology of Addiction Tiffany Love, Ph.D. Department of Psychiatry The University of Utah What is Addiction? Addiction is a chronic, relapsing, and treatable brain disorder. Compulsive drug seeking
More informationTO BE MOTIVATED IS TO HAVE AN INCREASE IN DOPAMINE. The statement to be motivated is to have an increase in dopamine implies that an increase in
1 NAME COURSE TITLE 2 TO BE MOTIVATED IS TO HAVE AN INCREASE IN DOPAMINE The statement to be motivated is to have an increase in dopamine implies that an increase in dopamine neurotransmitter, up-regulation
More informationThe Adolescent Developmental Stage
The Adolescent Developmental Stage o Physical maturation o Drive for independence o Increased salience of social and peer interactions o Brain development o Inflection in risky behaviors including experimentation
More informationCouncil on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain
Council on Chemical Abuse Annual Conference November 2, 2017 The Science of Addiction: Rewiring the Brain David Reyher, MSW, CAADC Behavioral Health Program Director Alvernia University Defining Addiction
More informationNeurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP
Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the
More informationThe Nervous System Mark Stanford, Ph.D.
The Nervous System Functional Neuroanatomy and How Neurons Communicate Mark Stanford, Ph.D. Santa Clara Valley Health & Hospital System Addiction Medicine and Therapy Services The Nervous System In response
More informationCatherine Dulac, Ph.D. Chair and Higgins Professor of Molecular and Cellular Biology Howard Hughes Medical Institute Investigator Harvard University
Klarman Family Foundation Grants Program in Eating Disorders Research 2009 Award Recipients, Two-Year Grants Catherine Dulac, Ph.D. Chair and Higgins Professor of Molecular and Cellular Biology Howard
More informationNicotine Receptors in the Brain: Implications for Addiction and Depression
Nicotine Receptors in the Brain: Implications for Addiction and Depression Marina Picciotto, Charles BG Murphy Professor in Psychiatry Professor of Neuroscience and Pharmacology Yale University The problem:
More informationThe Neurobiology of Psychiatric Disorders
The Neurobiology of Psychiatric Disorders Vikaas S. Sohal, MD PhD Department of Psychiatry Center for Integrative Neuroscience Sloan Swartz Center for Theoretical Neurobiology Overview 1. Classification
More informationThe Neuroscience of Addiction: A mini-review
The Neuroscience of Addiction: A mini-review Jim Morrill, MD, PhD MGH Charlestown HealthCare Center Massachusetts General Hospital Disclosures Neither I nor my spouse/partner has a relevant financial relationship
More informationLESSON 3.4 WORKBOOK. Can you become addicted to food?
DEFINITIONS OF TERMS Dopamine A compound that sends signals from one neuron to another, and is made from the amino acid tyrosine. Dopamine reward pathway A circuit in the brain that when activated leads
More informationbiological psychology, p. 40 The study of the nervous system, especially the brain. neuroscience, p. 40
biological psychology, p. 40 The specialized branch of psychology that studies the relationship between behavior and bodily processes and system; also called biopsychology or psychobiology. neuroscience,
More informationAt a Glance. Background Information. Lesson 3 Drugs Change the Way Neurons Communicate
Lesson 3 Drugs Change the Way Neurons Communicate Overview Students build upon their understanding of neurotransmission by learning how different drugs of abuse disrupt communication between neurons. Students
More informationThe Neurobiology of Mood Disorders
The Neurobiology of Mood Disorders J. John Mann, MD Professor of Psychiatry and Radiology Columbia University Chief, Department of Neuroscience, New York State Psychiatric Institute Mood Disorders are
More informationShift 1, 8 July 2018, 09:30-13:00
Shift 1, 8 July 2018, 09:30-13:00 CNS patterning A001-A014 Stem cells: basic biology and postnatal neurogenesis - part I Development of neural systems: Molecular and genetic characterisationa Epigenetic
More informationGenetics of Behavior (Learning Objectives)
Genetics of Behavior (Learning Objectives) Recognize that behavior is multi-factorial with genetic components Understand how multi-factorial traits are studied. Explain the terms: prevalence, incidence,
More informationEighth Edition. Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas
Eighth Edition Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas 1 < < < Evolution of our Human Brain: Spinal Cord to Diencephalon to Mammalian-Meso Cortex to Neo Cortex
More informationBasic definition and Classification of Anhedonia. Preclinical and Clinical assessment of anhedonia.
Basic definition and Classification of Anhedonia. Preclinical and Clinical assessment of anhedonia. Neurobiological basis and pathways involved in anhedonia. Objective characterization and computational
More informationThe Role of Smoking in Cocaine. Addiction
The Role of Smoking in Cocaine Addiction Luca Colnaghi Eric Kandel Laboratory Columbia University in the City of New York Department of Neuroscience Index 1- The Brain, memory, metaplasticity 2- Cocaine
More informationNeurophysiology of the Regulation of Food Intake and the Common Reward Pathways of Obesity and Addiction. Laura Gunter
Neurophysiology of the Regulation of Food Intake and the Common Reward Pathways of Obesity and Addiction Laura Gunter The Brain as the Regulatory Center for Appetite The brain is the integration center
More informationFood restriction: enhancing effects on drug reward and striatal cell signaling
Food restriction: enhancing effects on drug reward and striatal cell signaling K.D. Carr Departments of Psychiatry & Pharmacology NYU School of Medicine Common Neural Substrates for Incentive-Motivating
More informationNEUROBIOLOGY ALCOHOLISM
NEUROBIOLOGY ALCOHOLISM THERE HAS BEEN A MAJOR THEORETICAL SHIFT IN MEDICATION DEVELOPMENT IN ALCOHOLISM Driven by animal models of intermittent ethanol administration followed by termination, then access
More informationIngestive Behavior: Feeding & Weight Regulation. Hypovolemic vs. Osmotic Thirst
Ingestive Behavior: Feeding & Weight Regulation 1 Hypovolemic Thirst Receptors, CNS, Responses Salt Appetite Digestive components Glucose Homeostasis: Insulin & Glucagon Diabetes Mellitus 1 & 2 CNS Hypothalamic
More informationSerotonin System May Have Potential as a Target for Cocaine Medications
NIDA - Publications - NIDA Notes - Vol. 21, No. 3 - Research Findings of 4 http://www.drugabuse.gov/nida_notes/nnvol21n3/serotonin.html 9/26/2011 3:45 PM NIDA NEWS NIDA Home > Publications > NIDA Notes
More informationDrugs, addiction, and the brain
Drugs, addiction, and the brain Topics to cover: What is addiction? How is addiction studied in the lab? The neuroscience of addiction. Caffeine Cocaine Marijuana (THC) What are the properties of addiction?
More informationGenetics of Behavior (Learning Objectives)
Genetics of Behavior (Learning Objectives) Recognize that behavior is multi-factorial with genetic components Understand how multi-factorial traits are studied. Explain the terms: incidence, prevalence,
More informationAcetylcholine (ACh) Action potential. Agonists. Drugs that enhance the actions of neurotransmitters.
Acetylcholine (ACh) The neurotransmitter responsible for motor control at the junction between nerves and muscles; also involved in mental processes such as learning, memory, sleeping, and dreaming. (See
More informationChapter 12. Ingestive Behavior
Chapter 12 Ingestive Behavior Drinking a. fluid compartments b. osmometric thirst c. volumetric thirst Eating a. energy sources b. starting a meal c. stopping a meal d. eating disordersd Drinking a. fluid
More informationBrain Mechanisms of Emotion 1 of 6
Brain Mechanisms of Emotion 1 of 6 I. WHAT IS AN EMOTION? A. Three components (Oately & Jenkins, 1996) 1. caused by conscious or unconscious evaluation of an event as relevant to a goal that is important
More informationBrain Imaging studies in substance abuse. Jody Tanabe, MD University of Colorado Denver
Brain Imaging studies in substance abuse Jody Tanabe, MD University of Colorado Denver NRSC January 28, 2010 Costs: Health, Crime, Productivity Costs in billions of dollars (2002) $400 $350 $400B legal
More informationΝευροφυσιολογία και Αισθήσεις
Biomedical Imaging & Applied Optics University of Cyprus Νευροφυσιολογία και Αισθήσεις Διάλεξη 16 Κίνητρα Συμπεριφοράς ή Υποκίνηση (Motivation) Introduction Types of behavior Unconscious reflexes Voluntary
More informationCogs 107b Systems Neuroscience lec9_ neuromodulators and drugs of abuse principle of the week: functional anatomy
Cogs 107b Systems Neuroscience www.dnitz.com lec9_02042010 neuromodulators and drugs of abuse principle of the week: functional anatomy Professor Nitz circa 1986 neurotransmitters: mediating information
More informationESSENTIAL PSYCHOPHARMACOLOGY, Neurobiology of Schizophrenia Carl Salzman MD Montreal
ESSENTIAL PSYCHOPHARMACOLOGY, 2011 Neurobiology of Schizophrenia Carl Salzman MD Montreal EVOLVING CONCEPTS OF SCHIZOPHRENIA Psychotic illness with delusions, hallucinations, thought disorder and deterioration;
More informationTitle: Pinpointing resilience in Bipolar Disorder
Title: Pinpointing resilience in Bipolar Disorder 1. AIM OF THE RESEARCH AND BRIEF BACKGROUND Bipolar disorder (BD) is a mood disorder characterised by episodes of depression and mania. It ranks as one
More informationnucleus accumbens septi hier-259 Nucleus+Accumbens birnlex_727
Nucleus accumbens From Wikipedia, the free encyclopedia Brain: Nucleus accumbens Nucleus accumbens visible in red. Latin NeuroNames MeSH NeuroLex ID nucleus accumbens septi hier-259 Nucleus+Accumbens birnlex_727
More informationKen Winters, Ph.D. Department of Psychiatry University of Minnesota Midwest Conference on Problem Gambling August 11, 2004
Adolescent Brain Development, Substance Use and Gambling Involvement Ken Winters, Ph.D. Department of Psychiatry University of Minnesota winte001@umn.edu Midwest Conference on Problem Gambling August 11,
More informationKey Concepts. Machinery of the Mind. The Growing Cycle. Six Brain Mind Functions. Machinery of the Mind 6/1/2012
Machinery of the Mind How High-risk Choices Redesign the Brain Key Concepts Brain and Mind are reciprocal Brain/Mind Functions intertwine We are hardwired and we have software Your brain changes all the
More informationPsychology 320: Topics in Physiological Psychology Lecture Exam 2: March 19th, 2003
Psychology 320: Topics in Physiological Psychology Lecture Exam 2: March 19th, 2003 Name: Student #: BEFORE YOU BEGIN!!! 1) Count the number of pages in your exam. The exam is 8 pages long; if you do not
More informationClasses of Neurotransmitters. Neurotransmitters
1 Drugs Outline 2 Neurotransmitters Agonists and Antagonists Cocaine & other dopamine agonists Alcohol & its effects / Marijuana & its effects Synthetic & Designer Drugs: Ecstasy 1 Classes of Neurotransmitters
More informationBio11: The Nervous System. The human brain. fmri scans of the brain a tool for brain mapping. MRI image of the head. Neurons carry electrical signals
Bio11: The Nervous System The human brain The brain processes and acts on information Home of intelligence Uses more energy than any other part of the body Mysteries of human brain 4:37 http://www.youtube.com/watch?v=glxu80ge7vg
More informationMotivation 1 of 6. during the prandial state when the blood is filled
Motivation 1 of 6 I. INTRODUCTION A. Motivation: a condition (usually internal) that initiates, activates, or maintains goal-directed behavior. B. Archery analogy 1. undrawn bow has no potential energy
More informationNEUROSCIENCE. W1 Divisions of the nervous system PSYC1002 NOTES
PSYC1002 NOTES NEUROSCIENCE W1 Divisions of the nervous system Nervous system: - CNS o Brain and spinal cord - Peripheral Nervous System o Sensory nerves o Motor nerves o Autonomic nervous system o Enteric
More informationThe Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison
The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison Attitudes about addiction and recovery throughout history Disease?
More informationEffects of lesions of the nucleus accumbens core and shell on response-specific Pavlovian i n s t ru mental transfer
Effects of lesions of the nucleus accumbens core and shell on response-specific Pavlovian i n s t ru mental transfer RN Cardinal, JA Parkinson *, TW Robbins, A Dickinson, BJ Everitt Departments of Experimental
More informationManagement of Tobacco Dependence. Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur
Management of Tobacco Dependence Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur Difficult to identify any other condition that presents such a mix of lethality, prevalence,
More informationAbstracts and affiliations
Dopamine Discovery Day August 30, 2012 Rikshospitalet Store auditorium, Oslo, Norway Organized by Linda H. Bergersen & Vidar Gundersen Institute of Basic Medical Sciences & Centre for Molecular Biology
More informationCorticostriatal-hypothalamic circuitry and food motivation: integration of energy, reward, and action
1 Corticostriatal-hypothalamic circuitry and food motivation: integration of energy, reward, and action Ann E. Kelley, Brian A. Baldo, Wayne E. Pratt and Matthew J. Will 1 Department of Psychiatry University
More informationStressin with Ghrelin. Peptide Pods: Lara, Elijah, Karen, Brandon, Milena, Max & Lucile
Stressin with Ghrelin Peptide Pods: Lara, Elijah, Karen, Brandon, Milena, Max & Lucile Agenda Ghrelin Essentials Review Associations of Ghrelin with eating, stress, metabolic factors, etc. High-fat diet
More informationKnowing How Gamblers Think: Improving Treatment Outcomes
Knowing How Gamblers Think: Improving Treatment Outcomes Jon E. Grant, JD, MD, MPH Professor University of Minnesota School of Medicine Minneapolis, MN Disclosure Information I have the following financial
More informationEvidence-Based Treatment Approaches for Gambling Disorder
Evidence-Based Treatment Approaches for Gambling Disorder Jon E. Grant, JD, MD, MPH Professor University of Chicago Pritzker School of Medicine Chicago, IL 6/8/2016 Disclosure Information My research is
More information22 JWA :00-15:
22 JWA 2018 2018 7 7 13:00-15:00 1 2 1702004 2018 7 7 Saturday, 7 th July, 2018 12:30-2F 1 13:00-14:00 1 (SL-1) Special Lecture 1 Monoaminergic drugs vs. fast-acting antidepressants: effects on glutamate
More informationThe Nervous System. Biological School. Neuroanatomy. How does a Neuron fire? Acetylcholine (ACH) TYPES OF NEUROTRANSMITTERS
Biological School The Nervous System It is all about the body!!!! It starts with an individual nerve cell called a NEURON. Synapse Neuroanatomy Neurotransmitters (chemicals held in terminal buttons that
More informationThe Biology of Addiction
The Biology of Addiction Risk factors for addiction: Biological/Genetic Family history of addiction Being male Having mental illness Exposure to substances in utero * The genes that people are born with
More information- Neurotransmitters Of The Brain -
- Neurotransmitters Of The Brain - INTRODUCTION Synapsis: a specialized connection between two neurons that permits the transmission of signals in a one-way fashion (presynaptic postsynaptic). Types of
More informationPsychoactive Drugs & The Brain
Psychoactive Drugs & The Brain Psychoactive Substances & The Brain 1. Psychoactive substances enter the bloodstream via oral administration, inhalation, smoking, or injection 2. Psychoactive substances
More informationGoal: To identify the extent to which different aspects of brain structure and brain processes might offer explanations for different forms of
Goal: To identify the extent to which different aspects of brain structure and brain processes might offer explanations for different forms of psychopathology The human brain If genetics play a role, it
More informationThinking Outside the Box: Prescribing by Synthesis & Integration
Thinking Outside the Box: Prescribing by Synthesis & Integration Barbara J. Limandri, DNSc, APRN, BC Linfield College School of Nursing Portland DBT Program AGENDA Neuroanatomy and neurophysiology review
More informationWhat can we do to improve the outcomes for all adolescents? Changes to the brain and adolescence-- Structural and functional changes in the brain
The Adolescent Brain-- Implications for the SLP Melissa McGrath, M.A., CCC-SLP Ball State University Indiana Speech Language and Hearing Association- Spring Convention April 15, 2016 State of adolescents
More informationMeCP2 and psychostimulantinduced behavioral adaptations. Anne E. West, M.D., Ph.D. Department of Neurobiology Duke University Medical Center
MeCP2 and psychostimulantinduced behavioral adaptations Anne E. West, M.D., Ph.D. Department of Neurobiology Duke University Medical Center Psychostimulants and antidepressants slowly change behavior Psychostimulants
More informationPart IV: Slipping Up: Neuroscience Basis of Relapse & Recovery July 31, am 12:30 pm with Break 10-10:15am
Eighth Edition Congratulations and Thank You All for Attending Part IV: Slipping Up: Neuroscience Basis of Relapse & Recovery July 31, 2015 8 am 12:30 pm with Break 10-10:15am Preventing Recrudescence
More informationBiomarkers in Schizophrenia
Biomarkers in Schizophrenia David A. Lewis, MD Translational Neuroscience Program Department of Psychiatry NIMH Conte Center for the Neuroscience of Mental Disorders University of Pittsburgh Disease Process
More informationWhat makes us ill?
www.unifr.ch/psycho/en/research/psycli What makes us ill? What makes us ill? Looking for vulnerability factors for mental illness Prof. Dr. Chantal Martin-Soelch In the framework of the burden of mental
More informationThe Role of NEUROIMAGING In Diagnostic and Clinical Practice
The Role of NEUROIMAGING In Diagnostic and Clinical Practice ADHD Schizophrenia Autism Addiction Altzheimer s Disease Nora D. Volkow, M.D. Director National Institute on Drug Abuse National Institutes
More informationECHO Presentation Addiction & Brain Function
ECHO Presentation Addiction & Brain Function May 23 rd, 2018 Richard L. Bell, Ph.D. Associate Professor of Psychiatry Indiana University School of Medicine ribell@iupui.edu Development of Addiction Addiction
More informationPART I. Neural Foundations of Behavior: The Basic Equipment
Detailed Contents Preface xiii About the Author xvi chapter 1. What Is Biopsychology? 1 The Origins of Biopsychology 3 Prescientific Psychology and the Mind-Brain Problem 4 Descartes and the Physical Model
More informationCNS Control of Food Intake. Adena Zadourian & Andrea Shelton
CNS Control of Food Intake Adena Zadourian & Andrea Shelton Controlling Food Intake Energy Homeostasis (Change in body adiposity + compensatory changes in food intake) Background Information/Review Insulin
More informationBrain Stimulation in the Study and Treatment of Addiction. From Animal Models to Humans
The Weizmann Institute of Science Brain Stimulation in the Study and Treatment of Addiction From Animal Models to Humans Abraham Zangen Department of Neurobiology The Weizmann Institute of Science Drug
More informationChapter 7. Discussion and impact
Chapter 7 Discussion and impact 225 Affective pathology is a complex construct which encompasses a pathological disturbance in primary emotions, rapidly shifting from neutral to intense perception, associated
More informationNeurotransmitter Functioning In Major Depressive Disorder
Neurotransmitter Functioning In Major Depressive Disorder Otsuka Pharmaceutical Development & Commercialization, Inc. 2017 Otsuka Pharmaceutical Development & Commercialization, Inc., Rockville, MD January
More informationDrugs, The Brain, and Behavior
Drugs, The Brain, and Behavior John Nyby Department of Biological Sciences Lehigh University What is a drug? Difficult to define Know it when you see it Neuroactive vs Non-Neuroactive drugs Two major types
More informationCHAPTER 2. THE NEUROBIOLOGY OF SUBSTANCE USE, MISUSE, AND ADDICTION
CHAPTER 2. THE NEUROBIOLOGY OF SUBSTANCE USE, MISUSE, AND ADDICTION Chapter 2 Preview A substantial body of research has accumulated over several decades and transformed our understanding of substance
More informationThe Biological Perspective. Jørg Mørland Senior researcher, Norwegian Institute of Public Health Professor em of Medicine University of Oslo
The Biological Perspective Jørg Mørland Senior researcher, Norwegian Institute of Public Health Professor em of Medicine University of Oslo The Biological Perspective What is it? More than «the» one biological
More informationBi156 lecture 2, 1/6/12. Eating and weight regulation
Bi156 lecture 2, 1/6/12 Eating and weight regulation Introduction: weight regulation in an affluent society In our society much effort and money is expended on regulation of weight. Failure to maintain
More information6B / Boswell, Grant and Slutske Day 2 August 14, 2008
Pharmacological Treatment of Pathological Gambling Jon E. Grant, JD, MD, MPH Associate Professor University of Minnesota School of Medicine Minneapolis, MN Disclosure Information I have the following financial
More informationEmotion Dysregulation: Consequences and Mechanisms
Emotion Dysregulation: Consequences and Mechanisms 5 th Purdue Symposium on Psychological Sciences Sponsored by the Department of Psychological Sciences at Purdue University Monday May 16 and Tuesday May
More informationUnderstanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO
Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year
More informationIf you give any person a prescription of something like Valium and have them take it on
As always I am happy to do this presentation, which is my favorite topic in addiction medicine. I am an internist, and I have done healthcare for the homeless in Springfield as well as been the medical
More informationThe future of pharmacological treatment.
The future of pharmacological treatment. Anne Lingford-Hughes Professor of Addiction Biology, Imperial College. Hon Consultant CNWL NHS Foundation Trust. What substances and when? What Nicotine Alcohol
More informationMANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER
MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners Grand Rounds October 11, 2017 Disclosures One
More informationOrexin and Sleep. Team: A Little Bit of Leptin
Orexin and Sleep Team: A Little Bit of Leptin Intro to Orexin 1997 -Scripps Research Institute gene expression in the hypothalamus Found gene clone 35 - expression limited to the lateral hypothalamus NTs
More informationGeneral introduction. Chapter 1
General introduction Chapter 1 General introduction Historical aspects of drug use Religious, medicinal and recreational use of mind-altering substances by humans has a history of thousands of years 1.
More informationCopyright 2017 The Guilford Press
This is a chapter excerpt from Guilford Publications. Eating Disorders and Obesity: A Comprehensive Handbook, Third Edition. Edited by Kelly D. Brownell and B. Timothy Walsh. Copyright 2017. Purchase this
More informationAmerica is a drugged society
Overview of Drug Abuse Basic Considerations. M. Imad Damaj, Ph.D. Associate Professor Dept. of Pharmacology/Toxicology, Virginia Commonwealth University America is a drugged society 90% of all drugs manufactured
More informationUnderstanding the Brain: What Drugs Can Tell Us
LIVE INTERACTIVE LEARNING @ YOUR DESKTOP Understanding the Brain: What Drugs Can Tell Us Presented by: Dr. Rochelle D. Schwartz-Bloom March 24, 2011 Understanding the Brain: What Drugs Can Tell Us Rochelle
More informationInsulin-Leptin Interactions
Insulin-Leptin Interactions Ahmed S., Al-Azzam N., Cao B. Karshaleva B., Sriram S., Vu K. If you understand a system, you can predict it. Agenda - Energy homeostasis Overview of leptin and insulin Signaling
More informationNeurobiology of Pain and Addiction
T. Celeste Napier, Ph.D. Neurobiology of Pain and Addiction Focus on Opioids Professor, Department of Psychiatry Director, Center for Compulsive Behavior and Addiction Disclosures In the past three years,
More informationThe Neurobiology of Schizophrenia
The Neurobiology of Schizophrenia Dost Ongur, MD PhD Neither I nor my spouse/partner has a relevant financial relationship with a commercial interest to disclose. What is Psychosis? Response Language Affect
More informationThe Neurobiology of Addiction. Angela Haliburda, DO
The Neurobiology of Addiction Angela Haliburda, DO Currently, 8-10% of those age 12+ years, or 20 million to 22 million Americans are addicted to alcohol or other drugs. Drug overdoses are now the leading
More informationModulation of the Neural Circuitry Underlying Obsessive-Compulsive Disorder
BRAIN STIMULATION LABORATORY Modulation of the Neural Circuitry Underlying Obsessive-Compulsive Disorder OCD Awareness Day NOLAN WILLIAMS, M.D. Instructor Department of Psychiatry Stanford University October
More informationChapter 3. Biological Processes
Biological Processes Psychology, Fifth Edition, James S. Nairne What s It For? Biological Solutions Communicating internally Initiating and coordinating behavior Regulating growth and other internal functions
More informationThe Physiology of Weight Regulation: Implications for Effective Clinical Care
Roundtable on Obesity Solutions The Physiology of Weight Regulation: Implications for Effective Clinical Care Lee M. Kaplan, MD, PhD Obesity, Metabolism & Nutrition Institute Massachusetts General Hospital
More informationTranscriptional and Epigenetic Mechanisms of Addiction
Transcriptional and Epigenetic Mechanisms of Addiction Eric J. Nestler Mount Sinai School of Medicine New York, NY Dr. Ray Fuller There is every reason to be optimistic that in the future we will find
More informationBasal Ganglia General Info
Basal Ganglia General Info Neural clusters in peripheral nervous system are ganglia. In the central nervous system, they are called nuclei. Should be called Basal Nuclei but usually called Basal Ganglia.
More information